Response Biomedical Corp-医療機器分野:企業M&A・提携分析

◆英語タイトル:Response Biomedical Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010883
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, NT-proBNP, CK-MB, and D-dimer; environmental test for West Nile disease; Biodefense tests for anthrax, smallpox, ricin and botulinum toxin; and Infectious disease tests for influenza A+B and respiratory syncytial virus. The company develops its diagnostic tests using its proprietary RAMP technology platform. It develops RAMP immunoassays for the clinical, pharmaceutical, industrial, environmental and agricultural applications. The company distributes its products through sales and distribution agreements with various companies. Response Biomedical is headquartered in Vancouver, British Columbia, Canada.

Response Biomedical Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Response Biomedical Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Response Biomedical Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Response Biomedical Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Response Biomedical Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Response Biomedical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Response Biomedical Corp, Medical Equipment, Deal Details 10
Partnerships 10
Response Biomedical Enters into Partnership with Alere Medical 10
Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical 11
Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 12
Stratos Product Development Enters Into Co-Development Agreement With Response Biomedical 13
Equity Offering 14
Response Biomedical Raises USD0.5 Million in First Tranche of Private Placement of Shares 14
Response Biomedical Completes Private Placement Of Subscription Receipts For US$1.5 Million 16
Response Biomedical Completes Non-Brokered Private Placement Of Subscription Receipts For US$1.5 Million 17
Response Biomedical Completes Rights Offering Of Units For US$6.6 Million 18
Acquisition 20
1077801 B.C. Ltd Acquires Response Biomedical 20
Response Biomedical Corp – Key Competitors 22
Response Biomedical Corp – Key Employees 23
Response Biomedical Corp – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 10, 2016: Response Biomedical Announces Third Quarter 2016 Financial Results 25
Aug 12, 2016: Response Biomedical Announces Second Quarter 2016 Financial Results 26
May 16, 2016: Response Biomedical Announces First Quarter 2016 Financial Results 27
Mar 21, 2016: Response Biomedical Announces Fourth Quarter and Fiscal 2015 Financial Results 28
Product News 30
02/18/2016: Response Biomedical Announces the Launch of the RAMP Dengue Test for Aedes aegypti and Aedes albopictus Mosquitoes 30
01/11/2016: Response Biomedical Receives Health Canada Approval and CE Mark for the RAMP Procalcitonin Test for Sepsis 31
Product Approvals 32
Jan 11, 2016: Response Biomedical Receives Health Canada Approval and CE Mark for the RAMP Procalcitonin Test for Sepsis 32
Other Significant Developments 33
Apr 07, 2016: Response Biomedical Awarded Capital Equipment Supplier Contract by Vizient 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Response Biomedical Corp, Medical Equipment, Key Facts 2
Response Biomedical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Response Biomedical Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Response Biomedical Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Response Biomedical Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Response Biomedical Corp, Deals By Market, 2011 to YTD 2017 8
Response Biomedical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Response Biomedical Enters into Partnership with Alere Medical 10
Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical 11
Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 12
Stratos Product Development Enters Into Co-Development Agreement With Response Biomedical 13
Response Biomedical Raises USD0.5 Million in First Tranche of Private Placement of Shares 14
Response Biomedical Completes Private Placement Of Subscription Receipts For US$1.5 Million 16
Response Biomedical Completes Non-Brokered Private Placement Of Subscription Receipts For US$1.5 Million 17
Response Biomedical Completes Rights Offering Of Units For US$6.6 Million 18
1077801 B.C. Ltd Acquires Response Biomedical 20
Response Biomedical Corp, Key Competitors 22
Response Biomedical Corp, Key Employees 23
Response Biomedical Corp, Other Locations 24
Response Biomedical Corp, Subsidiaries 24

★海外企業調査レポート[Response Biomedical Corp-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Whole Foods Market Inc:企業の戦略・SWOT・財務情報
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Paladin Energy Ltd.:企業の戦略的SWOT分析
    Paladin Energy Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Newfield Exploration Company (NFX)-石油・ガス分野:企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • AMC Networks Inc.:企業の戦略・SWOT・財務情報
    AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Indequity Group Limited:企業の戦略・SWOT・財務分析
    Indequity Group Limited - Strategy, SWOT and Corporate Finance Report Summary Indequity Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Debt Resolve Inc (DRSV):企業の財務・戦略的SWOT分析
    Summary Debt Resolve Inc (Debt Resolve) is a technology company that offers cloud-based software and services. The company develops and markets patent-based web collection technologies. It provides solutions for non-payment of bills, debts, damages and other financial disputes. Debt Resolve also off …
  • EMD Serono Inc-製薬・医療分野:企業M&A・提携分析
    Summary EMD Serono Inc (EMD), formerly Serono Inc, a subsidiary of Merck KGaA is a healthcare products provider that offers oncology products. The company offers neurology and immunology; metabolic endocrinology, fertility and oncology products. It offers neurology and immunology products to find ne …
  • Texas Children’s Hospital:企業の戦略的SWOT分析
    Texas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • XyloCor Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary XyloCor Therapeutics Inc (XyloCor Therapeutics) is a biopharmaceutical company that offers development of gene therapies for cardiovascular diseases. The company’s portfolio of pipeline products includes XC001 and XC002. It develops its products for the treatment of refractory angina and for …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Guardant Health Inc (GH):企業の製品パイプライン分析2018
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Mutuelle Generale de l’Education Nationale:企業の戦略的SWOT分析
    Mutuelle Generale de l'Education Nationale - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Astex Pharmaceuticals Inc:企業の戦略的SWOT分析
    Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) operates as a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents …
  • Masimo Corp (MASI):企業の財務・戦略的SWOT分析
    Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CPR Pharma Services Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary CPR Pharma Services Pty Ltd (CPR) is a contract research organization that offers drug development and clinical trial services. The organization's services include clinical project management and monitoring, data management, statistical and pharmacokinetic services, and bioanalytical service …
  • AngioChem Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AngioChem Inc (AngioChem) is a clinical-stage biotechnology company that discovers and develops new drugs to treat brain related disorders. The company’s products comprise oncology products, peptide antibody conjugates, antibody-drug conjugates, pain products and lysosomal storage diseases p …
  • Biomatrica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • Banca IFIS SpA:企業の戦略・SWOT・財務情報
    Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report Summary Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bet Shemesh Engines Holdings (1997) Ltd:企業の戦略・SWOT・財務分析
    Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report Summary Bet Shemesh Engines Holdings (1997) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆